The mosquito Aedes aegypti L. is an important vector of dengue, Zika, chikungunya and yellow fever viruses and remains a major public-health challenge in many tropical and subtropical settings [1][2]. Control of immature mosquito stages is a central component of integrated vector management because aquatic breeding sites can be targeted before adult emergence [3]. Conventional larvicides, including organophosphates and other synthetic insecticides, have contributed to vector suppression, but their repeated use has raised concerns about resistance development, environmental persistence and impacts on non-target organisms [1][2][4].

Botanical larvicides remain attractive because they contain diverse secondary metabolites that may act through multiple biological pathways; however, their efficacy varies considerably with plant species, plant part, solvent system, extraction method and formulation [5]-[7].

Plant-derived products are often proposed as complementary or alternative larvicidal agents because they may contain multiple bioactive compounds and may degrade more readily in the environment than some conventional insecticides [8][9]. Ethnobotanical knowledge provides a useful starting point for identifying candidate species. The African medicinal plants Albizia coriaria, Plectranthus barbatus, Carissa spinarum, Croton macrostachyus and Tylosema fassoglense have reported medicinal or bioactive properties and are therefore plausible candidates for preliminary screening [10]-[14].

However, the practical value of botanical larvicides cannot be inferred from mortality at a single high concentration. A candidate extract may show measurable laboratory activity yet remain unsuitable for field application if effective concentrations are too high, unstable, costly to produce or unsafe to non-target organisms. Quantitative dose-response measures, particularly LC₅₀ and LC₉₀ values with confidence limits, are therefore necessary to distinguish biological activity from operationally relevant potency [15][16].

This study evaluated the larvicidal activity of ethanolic extracts from five African medicinal plants against third-instar Ae. aegypti larvae. The specific aims were to estimate dose-response parameters using probit analysis, identify extracts with concentration-dependent activity, and assess whether the crude extracts show sufficient potency to justify consideration as direct larvicidal products or, alternatively, as sources for further phytochemical investigation.

Larval mortality varied substantially among the five plant extracts (Table 1). A. coriaria and P. barbatus produced concentration-dependent mortality, whereas C. spinarum, C. macrostachyus and T. fassoglense showed negligible activity across the tested concentration range. At 1.0% w/v, equivalent to 10,000 mg/L, A. coriaria caused 73.3% mortality and P. barbatus caused 56.2% mortality. The remaining extracts caused 0% - 6.7% mortality at the same concentration.

Table 1. Corrected 24 h mortality of third-instar Ae. aegypti larvae exposed to ethanolic plant extracts.

Because only A. coriaria and P. barbatus generated sufficient concentration-dependent mortality, probit analysis was restricted to these two extracts. P. barbatus produced an LC₅₀ estimate of 0.79% w/v, equivalent to 7,900 mg/L, while A. coriaria produced an LC₅₀ estimate of 0.91% w/v, equivalent to 9,100 mg/L (Table 2). Estimated LC₉₀ values were 1.31% for P. barbatus and 1.18% for A. coriaria. Both LC₉₀ estimates exceeded the maximum tested concentration of 1.0% w/v and should therefore be interpreted as model-based extrapolations rather than directly observed effective concentrations.

Table 2. Probit-derived toxicity estimates for extracts with concentration-dependent larval mortality.

The results indicate that crude ethanolic extracts from the five medicinal plants differed markedly in their larvicidal activity against Ae. aegypti. Only P. barbatus and A. coriaria produced concentration-dependent mortality, suggesting that these extracts may contain constituents with larvicidal activity. However, their LC₅₀ values were close to 1% w/v, and the LC₉₀ values were estimated beyond the highest tested concentration. This limits the immediate practical relevance of the crude extracts as direct larvicidal products.

The distinction between measurable activity and operational suitability is central to interpreting botanical larvicide studies. Extracts that achieve partial mortality at high laboratory concentrations may still be impractical for field use if large quantities of crude biomass are required. In this study, the active extracts required approximately 7,900 - 9,100 mg/L to achieve 50% mortality. Such concentrations may create logistical, economic and environmental constraints if translated directly into larval-source management. The findings therefore do not invalidate the ethnobotanical value of these plants, but they indicate that the crude ethanolic extracts should not be promoted as ready-to-use larvicides without further refinement. The distinction between measurable biological activity and operational relevance is important.

Recent studies on essential oils and selected plant extracts have reported LC₅₀ values in the low to moderate mg/L range, whereas the active crude extracts in the present study required concentrations in the thousands of mg/L [17]-[19].

The weak activity observed for C. spinarum, C. macrostachyus and T. fassoglense may reflect the inherent variability of crude botanical preparations. Larvicidal performance can be influenced by plant part, harvesting season, geographical origin, extraction solvent, extraction method, storage conditions, mosquito species, larval stage and assay design. Differences between the present findings and previous reports should therefore be interpreted as evidence that botanical larvicidal activity is highly context-dependent rather than as simple contradictions. For example, activity reported against one mosquito species or using a different solvent system may not be replicated against Ae. aegypti using crude ethanolic extracts [11][20].

Safety also requires careful consideration. The present study did not assess mammalian cytotoxicity, hemolytic activity, non-target aquatic toxicity or environmental persistence. Therefore, safety concerns should be treated as priorities for follow-up investigation rather than definitive conclusions from the current bioassay. Because some phytochemical groups commonly detected in medicinal plants, including saponins, alkaloids and polyphenols, can have broad biological effects, any future development should include selectivity testing against non-target organisms and mammalian cell models, as well as environmental degradation profiling [18][21]-[24].

Because larvicidal activity does not necessarily imply target selectivity, candidate botanical larvicides should be evaluated for cytotoxicity, non-target aquatic toxicity and environmental persistence before field application is considered [18][21]. Overall, the findings support a cautious development pathway. Crude extract screening remains useful for discovery, but the next stage should be bioassay-guided fractionation of P. barbatus and A. coriaria, followed by structural identification of active molecules, dose-response testing of purified fractions, formulation studies and safety assessment. A purified or enriched fraction may show higher potency than the crude extract; however, this must be demonstrated empirically before practical vector-control relevance can be claimed.

Under the tested laboratory conditions, ethanolic extracts of C. spinarum, C.macrostachyus and T. fassoglense showed negligible larvicidal activity against third-instar Ae. aegypti larvae. P. barbatus and A. coriaria produced concentration-dependent mortality, with LC₅₀ values of 0.79% and 0.91%, respectively. However, their LC₉₀ values were estimated above the maximum tested concentration, indicating that the crude extracts are unlikely to achieve high mortality at practical direct-use concentrations. The two active extracts may still be valuable as starting materials for bioassay-guided fractionation and compound discovery, provided that potency, selectivity, formulation feasibility and environmental safety are rigorously evaluated.

The author acknowledges the University of Nairobi School of Biological Sciences insectary for providing standardized Ae. aegypti larvae. Mutiso Kyallo of the University of Nairobi Herbarium is thanked for his technical assistance. The knowledge guiding this study originates from and remains the intellectual and cultural heritage of the Kuria and Luo communities of southwestern Kenya and any future therapeutic or commercial applications derived from this work should be pursued with equitable benefit-sharing, ethical engagement and full respect for indigenous intellectual property rights.